Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Avoro Capital Advisors LLC has filed 312 SEC EDGAR filings since 13 Feb 2015

SEC filing history

Showing 176-200 of 312 matching filings.

Per page
25
Current page
8
SC 13G

GENOCEA BIOSCIENCES, INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

IOVANCE BIOTHERAPEUTICS, INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

CONSTELLATION PHARMACEUTICALS, INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

FENNEC PHARMACEUTICALS INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ADVERUM BIOTECHNOLOGIES, INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

MIRATI THERAPEUTICS, INC.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
16 Nov 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

4

Filing date
23 Oct 2020
Reporting date
23 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

IMMUNOMEDICS, INC.

Filing date
23 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CYMABAY THERAPEUTICS, INC.

Filing date
01 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
14 Aug 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-36500

3 filing

Filing date
05 Aug 2020
Reporting date
03 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

4

Filing date
22 Jun 2020
Reporting date
18 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-16573

13F-HR filing

Filing date
15 May 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

4 filing

Filing date
01 May 2020
Reporting date
01 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-12104

4

Filing date
20 Mar 2020
Reporting date
20 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

IOVANCE BIOTHERAPEUTICS, INC.

Filing date
24 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CUE BIOPHARMA, INC.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

INTEC PHARMA LTD.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KARYOPHARM THERAPEUTICS INC.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CYMABAY THERAPEUTICS, INC.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

AMICUS THERAPEUTICS, INC.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CONSTELLATION PHARMACEUTICALS INC

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

BIODELIVERY SCIENCES INTERNATIONAL, INC.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .